Healthcare provider profile · identity verified

Steven John Granier, MD

Internal Medicine · NEW ORLEANS, LA · NPI 1578511499

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	834	249
Amlodipine Besylate	Amlodipine Besylate	790	219
Levothyroxine Sodium	Levothyroxine Sodium	425	116
Omeprazole	Omeprazole	325	91
Pravastatin Sodium	Pravastatin Sodium	293	83
Losartan Potassium	Losartan Potassium	289	85
Alprazolam	Alprazolam	273	45
Metformin Hcl	Metformin Hcl	266	79
Gabapentin	Gabapentin	253	72
Lisinopril	Lisinopril	247	70
Hydrochlorothiazide	Hydrochlorothiazide	244	68
Rosuvastatin Calcium	Rosuvastatin Calcium	226	72
Tamsulosin Hcl	Tamsulosin Hcl	225	66
Metoprolol Succinate	Metoprolol Succinate	209	66
Pantoprazole Sodium	Pantoprazole Sodium	205	57
Allopurinol	Allopurinol	159	45
Alendronate Sodium	Alendronate Sodium	158	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	156	25
Eliquis	Apixaban	152	30
Furosemide	Furosemide	140	46
Escitalopram Oxalate	Escitalopram Oxalate	139	37
Potassium Chloride	Potassium Chloride	133	39
Zolpidem Tartrate	Zolpidem Tartrate	130	32
Meloxicam	Meloxicam	124	46
Lorazepam	Lorazepam	122	19
Carvedilol	Carvedilol	121	36
Valsartan	Valsartan	118	37
Atenolol	Atenolol	114	31
Citalopram Hbr	Citalopram Hydrobromide	110	29
Simvastatin	Simvastatin	108	35
Clopidogrel	Clopidogrel Bisulfate	98	32
Tramadol Hcl	Tramadol Hcl	97	22
Fluticasone Propionate	Fluticasone Propionate	93	43
Albuterol Sulfate Hfa	Albuterol Sulfate	87	25
Ezetimibe	Ezetimibe	87	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	80	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	74	suppressed
Jardiance	Empagliflozin	72	15
Doxazosin Mesylate	Doxazosin Mesylate	70	21
Trazodone Hcl	Trazodone Hcl	69	18
Finasteride	Finasteride	68	23
Metoprolol Tartrate	Metoprolol Tartrate	68	19
Metformin Hcl Er	Metformin Hcl	67	21
Sertraline Hcl	Sertraline Hcl	65	19
Nifedipine Er	Nifedipine	64	19
Benazepril Hcl	Benazepril Hcl	63	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	26
Irbesartan	Irbesartan	55	16
Esomeprazole Magnesium	Esomeprazole Magnesium	53	17
Hydroxyzine Hcl	Hydroxyzine Hcl	53	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	18
Bupropion Xl	Bupropion Hcl	52	12
Ozempic	Semaglutide	52	14
Clonazepam	Clonazepam	50	suppressed
Chlorthalidone	Chlorthalidone	49	13
Duloxetine Hcl	Duloxetine Hcl	49	12
Fluoxetine Hcl	Fluoxetine Hcl	49	13
Xarelto	Rivaroxaban	48	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	47	14
Buspirone Hcl	Buspirone Hcl	44	13
Celecoxib	Celecoxib	43	12
Glipizide	Glipizide	43	12
Synthroid	Levothyroxine Sodium	40	13
Famotidine	Famotidine	39	12
Naproxen	Naproxen	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	12
Ramipril	Ramipril	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	18
Glipizide Er	Glipizide	35	11
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	32
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Donepezil Hcl	Donepezil Hcl	33	11
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Amoxicillin	Amoxicillin	32	24
Dicyclomine Hcl	Dicyclomine Hcl	32	12
Propranolol Hcl	Propranolol Hcl	32	suppressed
Montelukast Sodium	Montelukast Sodium	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	12
Alfuzosin Hcl Er	Alfuzosin Hcl	29	suppressed
Dutasteride	Dutasteride	29	suppressed
Verapamil Er	Verapamil Hcl	28	suppressed
Baclofen	Baclofen	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Novolog Flexpen	Insulin Aspart	26	suppressed
Spironolactone	Spironolactone	25	suppressed
Diazepam	Diazepam	24	suppressed
Mounjaro	Tirzepatide	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Topiramate	Topiramate	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Ondansetron Odt	Ondansetron	18	14
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Prednisone	Prednisone	17	15
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Warfarin Sodium	Warfarin Sodium	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Misoprostol	Misoprostol	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Estradiol	Estradiol	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Nitroglycerin	Nitroglycerin	13	11
Telmisartan	Telmisartan	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error